Related references
Note: Only part of the references are listed.Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin
Lauren J. Akers et al.
LEUKEMIA RESEARCH (2011)
Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate
Zhao Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the Warburg effect and a pivotal target for effective therapy
Saroj P. Mathupala et al.
SEMINARS IN CANCER BIOLOGY (2009)
Transcriptome profile of human colorectal adenomas
Jacob Sabates-Beliver et al.
MOLECULAR CANCER RESEARCH (2007)
The Warburg effect and its cancer therapeutic implications
Zhao Chen et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
p53 regulates mitochondrial respiration
Satoaki Matoba et al.
SCIENCE (2006)
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells
RH Xu et al.
LEUKEMIA (2005)
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ
G Achanta et al.
EMBO JOURNAL (2005)
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase
YH Ko et al.
CANCER LETTERS (2001)
Share Paper
